Helsinn announces European approval of the IV formulation of AKYNZEO® (fosnetupitant / palonosetron)
March 23, 2020 06:00 ET
|
Helsinn Healthcare S.A.
Helsinn announces European approval of the IV formulation of AKYNZEO® (fosnetupitant / palonosetron) Lugano, Switzerland, March 23, 2020 – Helsinn, the Swiss pharmaceutical group focused on building...